Skip to main navigation Skip to search Skip to main content

The bioactive peptide SL-13R expands human umbilical cord blood hematopoietic stem and progenitor cells in vitro

  • Kyushu University
  • Kyushu University, Faculty of Medical Sciences
  • Graduate School of Medical Sciences
  • Mahidol University
  • Angel Hospital
  • Hiroshima University

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

Hematopoietic stem and progenitor cell (HSPC) transplantation is a curative treatment of hematological disorders that has been utilized for several decades. Although umbilical cord blood (UCB) is a promising source of HSPCs, the low dose of HSPCs in these preparations limits their use, prompting need for ex vivo HSPC expansion. To establish a more efficient method to expand UCB HSPCs, we developed the bioactive peptide named SL-13R and cultured UCB HSPCs (CD34+ cells) with SL-13R in animal component-free medium containing a cytokine cocktail. Following 9 days of culture with SL-13R, the numbers of total cells, CD34+, CD38− cells, and hematopoietic stem cell (HSC)-enriched cells were significantly increased relative to control. Transplantation of cells cultured with SL-13R into immunodeficient NOD/Shi-scid/IL-2Rγ knockout mice confirmed that they possess long-term reconstitution and self-renewal ability. AHNAK, ANXA2, and PLEC all interact with SL-13R. Knockdown of these genes in UCB CD34+ cells resulted in reduced numbers of hematopoietic colonies relative to SL-13R-treated and non-knockdown controls. In summary, we have identified a novel bioactive peptide SL-13R promoting expansion of UCB CD34+ cells with long-term reconstitution and self-renewal ability, suggesting its clinical use in the future.

Original languageEnglish
Article number1995
JournalMolecules
Volume26
Issue number7
DOIs
Publication statusPublished - 1 Apr 2021

Keywords

  • Cell culture
  • Hematopoietic stem/progenitor cell
  • Peptide
  • Umbilical cord blood

Fingerprint

Dive into the research topics of 'The bioactive peptide SL-13R expands human umbilical cord blood hematopoietic stem and progenitor cells in vitro'. Together they form a unique fingerprint.

Cite this